The DOI matches its Crossref record.
Monocyte Chemoattractant Protein–1 Messenger RNA Expression in Rat Ischemic Cortex
Abstract
Background and Purpose Previously we demonstrated that focal cerebral ischemia results in an increased expression of several cytokines/chemokines that precede the infiltration of leukocytes into the ischemic cortex after focal stroke induced by occlusion of the middle cerebral artery (MCAO). Monocyte chemoattractant protein–1 (MCP-1) is a potent chemoattractant specific for monocytes. The aim of the present study was to examine whether MCP-1 messenger RNA (mRNA) is expressed in ischemic brain tissue after MCAO. Methods The expression of MCP-1 mRNA in the ischemic cortex was first identified by means of a sensitive reverse transcription and polymerase chain reaction technique. The time course of expression of MCP-1 mRNA in the ischemic and nonischemic cerebral cortex after both permanent MCAO and temporary MCAO (160 minutes) with reperfusion was then examined by means of Northern blot analysis. Results Almost no expression of MCP-1 mRNA was found in the sham-operated or nonischemic (contralateral) cortex. A significant increase in MCP-1 mRNA expression in the ischemic cortex was observed after either permanent or temporary MCAO. MCP-1 mRNA was elevated at 6 hours (4.4-fold increase over sham; n=4), reached its highest expression from 12 hours to 2 days (22.7-fold at the peak level; P <.01), and remained elevated up to 5 days (5.6-fold; P <.01) after permanent MCAO. The profile of MCP-1 mRNA expression in the ischemic cortex after MCAO with reperfusion was similar to that of permanent MCAO except that MCP-1 mRNA was increased earlier (ie, 12.5-fold increase at 3 hours; n=4; P <.01). Also, MCP-1 mRNA expression in the ischemic cortex after permanent MCAO was significantly greater in hypertensive rats than in two normotensive rats (n=4; P <.05). Conclusions The demonstration of induced MCP-1 mRNA expression early after focal ischemia suggests that MCP-1 may represent a locally expressed monocyte chemoattractant that plays an important role in monocyte infiltration into ischemic tissue and therefore may contribute to the tissue injury in ischemic stroke. Further studies must concentrate on identifying the induced expression of MCP-1 and its cellular localization in the ischemic brain when the appropriate antibodies become available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics
Barone, F. C., & Feuerstein, G. Z. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199908000-00001 · Cited by 930
Self-citationInflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 795
Inflammation in stroke and focal cerebral ischemia
Huang, J., Upadhyay, U. M., & Tamargo, R. J. (2006) · Surgical Neurology · doi:10.1016/j.surneu.2005.12.028 · Cited by 649
Experimental Stroke Induces Massive, Rapid Activation of the Peripheral Immune System
Offner, H., Subramanian, S., Parker, S. M., Afentoulis, M. E., Vandenbark, A. A., & Hurn, P. D. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600217 · Cited by 536
Cartier, L., Hartley, O., Dubois-Dauphin, M., & Krause, K.-H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 509
Post‐ischemic brain damage: pathophysiology and role of inflammatory mediators
Amantea, D., Nappi, G., Bernardi, G., Bagetta, G., & Corasaniti, M. T. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06766.x · Cited by 459
Chemokines and Their Receptors in the Central Nervous System
Bajetto, A., Bonavia, R., Barbero, S., Florio, T., & Schettini, G. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0214 · Cited by 416
Offner, H., Subramanian, S., Parker, S. M., Wang, C., Afentoulis, M. E., Lewis, A., Vandenbark, A. A., & Hurn, P. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6523 · Cited by 410
Mukaida, N., Harada, A., & Matsushima, K. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00022-1 · Cited by 401
T- and B-Cell-Deficient Mice with Experimental Stroke have Reduced Lesion Size and Inflammation
Hum, P. D., Subramanian, S., Parker, S. M., Afentoulis, M. E., Kaler, L. J., Vandenbark, A. A., & Offner, H. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600482 · Cited by 355
Iadecola, C., Zhang, F., Casey, R., Clark, H. B., & Ross, M. E. (1996) · Stroke · doi:10.1161/01.str.27.8.1373 · Cited by 322
Bajetto, A., Bonavia, R., Barbero, S., & Schettini, G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01091.x · Cited by 318
Monocyte Chemoattractant Protein-1 Deficiency is Protective in a Murine Stroke Model
Hughes, P. M., Allegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., & Wiessner, C. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200203000-00008 · Cited by 298
The neurovascular unit in the setting of stroke
Del Zoppo, G. J. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02199.x · Cited by 285
Mabuchi, T., Kitagawa, K., Ohtsuki, T., Kuwabara, K., Yagita, Y., Yanagihara, T., Hori, M., & Matsumoto, M. (2000) · Stroke · doi:10.1161/01.str.31.7.1735 · Cited by 280
Guido, S., Sebastian, J., & Schroeter, M. (2003) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0123-7_3 · Cited by 276
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning
Mennicken, F., Maki, R., de Souza, E. B., & Quirion, R. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01308-5 · Cited by 276
Chen, Y., Hallenbeck, J. M., Ruetzler, C., Bol, D., Thomas, K., Berman, N. E. J., & Vogel, S. N. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000071885.63724.20 · Cited by 276
Reperfusion Injury after Focal Cerebral Ischemia: The Role Inflammation and the The rapeutic Horizon
Jean, W. C., Spellman, S. R., Nussbaum, E. S., & Low, W. C. (1998) · Neurosurgery · doi:10.1097/00006123-199812000-00076 · Cited by 264
Inflammatory Responses in Brain Ischemia
Kawabori, M., & Yenari, M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666150209154036 · Cited by 262
BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells1
Gould, S. E., Day, M., Jones, S. S., & Dorai, H. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00103.x · Cited by 254
Effects of the Chemokine CCL2 on Blood–Brain Barrier Permeability during Ischemia–Reperfusion Injury
Dimitrijevic, O. B., Stamatovic, S. M., Keep, R. F., & Andjelkovic, A. V. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600229 · Cited by 252
“In the ischemic penumbra, CCL2 production was significant within 12 to 48 h (peak of expression) and persists for up to 5 days (Kim et al, 1995; Wang et al, 1995; Che et al, 2001).”
BackgroundMice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00033-4 · Cited by 222
Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage
YI, J., PARK, S., KAPADIA, R., & VEMUGANTI, R. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.04.019 · Cited by 206
Xie, L., Sun, F., Wang, J., Mao, X., Xie, L., Yang, S.-H., Su, D.-M., Simpkins, J. W., Greenberg, D. A., & Jin, K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303492 · Cited by 175
Metadata
- Authors
- Wang, X., Yue, T.-L., Barone, F. C., & Feuerstein, G. Z.
- Venue
- Stroke
- Published
- 1995-04
- Volume
- 26
- Issue
- 4
- Pages
- 661-666
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2141239782
- Cited by
- 196
- References
- 0
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.